MD Anderson Cancer Center Publication Shows How Bionano’s Saphyr System Can Significantly Reduce Time to Actionable Results for Myelodysplastic Syndrome Patients
January 19, 2021 08:00 ET
|
Bionano Genomics
In a head-to-head comparison against traditional cytogenomics methods, Saphyr identified all actionable variants, plus important variants missed, improving clinical stratification for patient...
Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 Illness
January 18, 2021 19:00 ET
|
Bionano Genomics
COVID-19 Host Genome Structural Variant (SV) Consortium used Saphyr to identify SVs in severe COVID-19 patients that affect genes involved in immunity, airway mucous, and viral replicationSVs found by...
Day Four of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy Testing
January 15, 2021 08:00 ET
|
Bionano Genomics
Saphyr can measure large expansions of disease-causing genomic repeats, impossible with other modern techniques, enabling study of a broad range of currently inaccessible genetic diseasesGenetic...
Day Three of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Provides Complete Structural Variation Analysis in Solid Tumors, Enables Discovery of Novel Diagnostic Markers and Drug Targets
January 14, 2021 08:00 ET
|
Bionano Genomics
Preliminary readout on Saphyr validation study for brain cancer presents path to solid tumor LDTSaphyr outperforms Oncoscan array for structural variation and copy number variation detection in solid...
Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
January 13, 2021 16:01 ET
|
Bionano Genomics
SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company...
Day Two of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard Cytogenetics in Heme Malignancies, is Less Expensive, Provides Actionable Information Faster, in Single Assay
January 13, 2021 08:00 ET
|
Bionano Genomics
Global customer consensus on Saphyr’s capability to identify actionable variants in hematological malignancies detected by several cytogenomic methods combinedSaphyr identifies additional variants...
Bionano Genomics Announces Closing of $101.8 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 12, 2021 17:04 ET
|
Bionano Genomics
SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (Nasdaq: BNGO), announced today the closing of its previously announced underwritten public offering of 33,368,851 shares of its...
Day One of Bionano’s Next-Generation Cytogenomics Symposium: Customer Progress in Applications Development in Prenatal Testing, Validation Against Traditional Cytogenetics and Resolution for Undiagnosed Patients
January 12, 2021 09:00 ET
|
Bionano Genomics
Path to LDT for prenatal genetic test of positive NIPT cases presented100% concordance with standard cytogenetic and molecular methods in genetic diseases reportedResolution of undiagnosed rare...
COVID-19 Host Genome SV Consortium Identifies Structural Variants with Possible Roles in Pathogenesis and Outcomes in Severely Ill COVID-19 Patients Using Bionano’s Saphyr® System
January 11, 2021 08:00 ET
|
Bionano Genomics
SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today the first publication from the COVID-19 Host Genome Structural Variant Consortium. The study found...
Bionano Genomics Announces the Kick-Off of its Next-Generation Cytogenomics Symposium, The Largest Event Yet to Showcase Saphyr’s Utility in Genome Analysis for Genetic Disease and Cancer
January 10, 2021 19:14 ET
|
Bionano Genomics
SAN DIEGO, Jan. 10, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the kick-off its 5-day Next-Generation Cytogenomics Symposium, which starts Monday January 11 and will...